Equity Research · Financial Services · Human Capital
| Market cap | Priceless |
|---|---|
| 52-wk range | Undergrad → MS Finance |
| Beta | High conviction |
| Dividend | Pays in insights |
| Float | Fully committed, no dilution |
| Exchange | Chicago, IL (relocated from Surat, India) |
| Auditor | Kellstadt Graduate School of Business |
JYT authored 70+ client valuation reports at Felix Advisory Private Limited across M&A and venture transactions — DCF, comparable company, precedent transaction, purchase price allocation, and option pricing work — plus integrated three-statement models supporting live deal execution and regulatory filings. This is recurring, high-margin analytical revenue, not a one-off gain.
The company independently authored a 12-page Nike vs. Under Armour financial statement analysis — five years of ratios, a differentiated turnaround thesis, and a clear call on the highest-leverage fix — alongside seven published reports spanning M&A, APV, real options, fixed income, and factor models. Management demonstrably does the job before being asked to.
Capital is being deployed into an MS in Finance at DePaul University's Kellstadt Graduate School of Business (3.85 GPA; expected June 2027), with operating leverage from serving as Vice President of Events, Kellstadt Finance Association. Pipeline visibility extends through graduation with multiple catalysts (see below).
Chart is illustrative, not to scale. Trajectory has never traded below its issue price. Past performance is, in this one case, highly indicative of future results.
Product in development: automated extraction and summarization of earnings-call transcripts. Expected to expand JYT's addressable market into quant-adjacent research tooling.
Continued equity research writing; each published note is an incremental proof point for the coverage franchise.
Speaker sessions, professional panels, and networking events organized as VP of Events — high-visibility distribution channel for the JYT brand.
Major re-rating event. Management expects full deployment into equity research / valuation roles at scale.
Independent 12-page, five-year ratio analysis. Thesis: brand and pricing power intact; profitability erosion self-inflicted via inventory mismanagement; balance sheet a fortress throughout.
Independent research note Download PDFNegative-NPV project reframed as a platform: abandonment put via binomial tree, second-generation growth call via Black-Scholes, and the $25.7M break-even hurdle that decides the launch.
Corporate finance case Download PDFFull M&A workup: synergized DCF at a 7.8% WACC (~$84/share), EBIAT-multiple cross-check, EPS accretion/dilution, sensitivity analysis, and a recommended $53–$55 stock-for-stock offer.
M&A model Download PDFHome-delivery project valued under all-equity, fixed perpetual and amortizing debt, and target-ratio WACC/APV — with the Miles-Ezzell consistency check landing both target-ratio answers on the same dollar.
APV / capital structure Download PDFFull fixed-income mechanics on a live 30-year Treasury: flat vs. invoice price, accrued interest day counts, Macaulay and modified duration, and yield sensitivity.
Fixed income Download PDF71 monthly observations, currency-adjusted. β = 0.93, R² = 0.655, with full t-test, F-test, ANOVA, and residual diagnostics on the emerging-market linkage.
Econometrics Download PDFSmall-cap value ETF decomposed into market, size, and value exposures. R² = 0.96; alpha statistically zero — returns explained almost entirely by systematic factor premia.
Factor models Download PDF| Risk | Assessment |
|---|---|
| Key-person risk | Severe and unhedgeable. There is only one of her. |
| Currency exposure | Fluent in finance jargon; translation costs for non-finance counterparties may apply. |
| Liquidity risk | Calendar fills quickly. Early positioning strongly advised. |
| Concentration risk | Portfolio heavily overweight spreadsheets. Management sees no reason to diversify. |
| Sleep (SLEEP ▼ −18%) | The single declining line item on the book. Correlated with coffee intake (r ≈ −0.97); management considers it a fair trade. |
| Regulatory risk | Subject to GPA maintenance covenants through June 2027. Currently in comfortable compliance at 3.85. |
| Asset class | Allocation | House view | Commentary |
|---|---|---|---|
| Fragrance portfolio | 38% | BUY | Each holding is mapped to its issuing company and carries an internal buy/hold/sell rating. Yes, really. The desk takes scent-to-equity coverage extremely seriously. |
| Book library | 32% | ACCUMULATE | Long-duration compounding assets. Shelf capacity is the binding constraint; management continues to add on weakness. |
| Equity research writing | 22% | OVERWEIGHT | Held for strategic purposes. Occasionally spun off into 12-page public filings (see Coverage History). |
| Cash & equivalents (free time) | 8% | UNDERWEIGHT | Structurally scarce. See "Liquidity risk," above. |
Allocations are approximate, unaudited, and subject to change without notice, particularly following fragrance launches.
Analyst certification. The analyst certifies that all views expressed in this report accurately reflect the analyst's personal opinion of the subject security, and that said opinion is 100% biased. The analyst is the subject security. No part of the analyst's compensation was, is, or will be tied to anything other than continuing to be excellent at valuation.
Important disclosures. The Market Itself does and seeks to do business with the company covered in this report (specifically: hiring her). Investors should be aware that the firm has a conflict of interest, in that the firm would very much like this to work out. Past performance is, contrary to standard disclaimer language, highly indicative of future results.
Price target methodology. The $107.80 price target is derived from a proprietary blend of DCF, comparable-candidate analysis, and unwavering conviction. Key model inputs include 70+ valuation reports, a 3.85 GPA, and an inexhaustible supply of Excel shortcuts. Downside scenarios were considered and dismissed.
Distribution. This report is distributed to recruiters, hiring managers, and anyone who typed the URL correctly. It is not an offer to sell securities. It is, however, an offer to schedule an interview. Ratings distribution: BUY 100%, HOLD 0%, SELL 0%. The firm stands by this distribution.
Rating definitions. BUY: expected to outperform expectations over the next 12 months. There are no other ratings.
© Jayati Vyas. Report JYT-IC-001. Not investment advice; excellent hiring advice.